Acute myeloid leukemia, version 3.2019

Martin S. Tallman; Eunice S. Wang; Jessica K. Altman; Frederick R. Appelbaum; Vijaya Raj Bhatt; Dale Bixby; Steven E. Coutre; Marcos De Lima; Amir T. Fathi; Melanie Fiorella; James M. Foran; Aric C. Hall; Meagan Jacoby; Jeffrey Lancet; Thomas W. LeBlanc; Gabriel Mannis; Guido Marcucci; Michael G. Martin; Alice Mims; Margaret R. O'Donnell; Rebecca Olin; Deniz Peker; Alexander Perl; Daniel A. Pollyea; Keith Pratz; Thomas Prebet; Farhad Ravandi; Paul J. Shami; Richard M. Stone; Stephen A. Strickland; Matthew Wieduwilt; Kristina M. Gregory; Lydia Hammond; Ndiya Ogba

doi:10.6004/jnccn.2019.0028

Acute myeloid leukemia, version 3.2019

Martin S. Tallman, Eunice S. Wang, Jessica K. Altman, Frederick R. Appelbaum, Vijaya Raj Bhatt, Dale Bixby, Steven E. Coutre, Marcos De Lima, Amir T. Fathi, Melanie Fiorella, James M. Foran, Aric C. Hall, Meagan Jacoby, Jeffrey Lancet, Thomas W. LeBlanc, Gabriel Mannis, Guido Marcucci, Michael G. Martin, Alice Mims, Margaret R. O'DonnellRebecca Olin, Deniz Peker, Alexander Perl, Daniel A. Pollyea, Keith Pratz, Thomas Prebet, Farhad Ravandi, Paul J. Shami, Richard M. Stone, Stephen A. Strickland, Matthew Wieduwilt, Kristina M. Gregory, Lydia Hammond, Ndiya Ogba

Research output: Contribution to journal › Article › peer-review

331 Scopus citations

Abstract

Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. Recent advances have resulted in an expansion of treatment options for AML, especially concerning targeted therapies and low-intensity regimens. This portion of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AML focuses on the management of AML and provides recommendations on the workup, diagnostic evaluation and treatment options for younger (age <60 years) and older (age ≥60 years) adult patients.

Original language	English
Pages (from-to)	721-749
Number of pages	29
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	17
Issue number	6
DOIs	https://doi.org/10.6004/jnccn.2019.0028
State	Published - 2019

Access to Document

10.6004/jnccn.2019.0028

Cite this

Tallman, M. S., Wang, E. S., Altman, J. K., Appelbaum, F. R., Bhatt, V. R., Bixby, D., Coutre, S. E., De Lima, M., Fathi, A. T., Fiorella, M., Foran, J. M., Hall, A. C., Jacoby, M., Lancet, J., LeBlanc, T. W., Mannis, G., Marcucci, G., Martin, M. G., Mims, A., ... Ogba, N. (2019). Acute myeloid leukemia, version 3.2019. JNCCN Journal of the National Comprehensive Cancer Network, 17(6), 721-749. https://doi.org/10.6004/jnccn.2019.0028

@article{d24bc69291b14517805f3766abefe971,

title = "Acute myeloid leukemia, version 3.2019",

abstract = "Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. Recent advances have resulted in an expansion of treatment options for AML, especially concerning targeted therapies and low-intensity regimens. This portion of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AML focuses on the management of AML and provides recommendations on the workup, diagnostic evaluation and treatment options for younger (age <60 years) and older (age ≥60 years) adult patients.",

author = "Tallman, {Martin S.} and Wang, {Eunice S.} and Altman, {Jessica K.} and Appelbaum, {Frederick R.} and Bhatt, {Vijaya Raj} and Dale Bixby and Coutre, {Steven E.} and {De Lima}, Marcos and Fathi, {Amir T.} and Melanie Fiorella and Foran, {James M.} and Hall, {Aric C.} and Meagan Jacoby and Jeffrey Lancet and LeBlanc, {Thomas W.} and Gabriel Mannis and Guido Marcucci and Martin, {Michael G.} and Alice Mims and O'Donnell, {Margaret R.} and Rebecca Olin and Deniz Peker and Alexander Perl and Pollyea, {Daniel A.} and Keith Pratz and Thomas Prebet and Farhad Ravandi and Shami, {Paul J.} and Stone, {Richard M.} and Strickland, {Stephen A.} and Matthew Wieduwilt and Gregory, {Kristina M.} and Lydia Hammond and Ndiya Ogba",

year = "2019",

doi = "10.6004/jnccn.2019.0028",

language = "English",

volume = "17",

pages = "721--749",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

number = "6",

}

Tallman, MS, Wang, ES, Altman, JK, Appelbaum, FR, Bhatt, VR, Bixby, D, Coutre, SE, De Lima, M, Fathi, AT, Fiorella, M, Foran, JM, Hall, AC, Jacoby, M, Lancet, J, LeBlanc, TW, Mannis, G, Marcucci, G, Martin, MG, Mims, A, O'Donnell, MR, Olin, R, Peker, D, Perl, A, Pollyea, DA, Pratz, K, Prebet, T, Ravandi, F, Shami, PJ, Stone, RM, Strickland, SA, Wieduwilt, M, Gregory, KM, Hammond, L & Ogba, N 2019, 'Acute myeloid leukemia, version 3.2019', JNCCN Journal of the National Comprehensive Cancer Network, vol. 17, no. 6, pp. 721-749. https://doi.org/10.6004/jnccn.2019.0028

TY - JOUR

T1 - Acute myeloid leukemia, version 3.2019

AU - Tallman, Martin S.

AU - Wang, Eunice S.

AU - Altman, Jessica K.

AU - Appelbaum, Frederick R.

AU - Bhatt, Vijaya Raj

AU - Bixby, Dale

AU - Coutre, Steven E.

AU - De Lima, Marcos

AU - Fathi, Amir T.

AU - Fiorella, Melanie

AU - Foran, James M.

AU - Hall, Aric C.

AU - Jacoby, Meagan

AU - Lancet, Jeffrey

AU - LeBlanc, Thomas W.

AU - Mannis, Gabriel

AU - Marcucci, Guido

AU - Martin, Michael G.

AU - Mims, Alice

AU - O'Donnell, Margaret R.

AU - Olin, Rebecca

AU - Peker, Deniz

AU - Perl, Alexander

AU - Pollyea, Daniel A.

AU - Pratz, Keith

AU - Prebet, Thomas

AU - Ravandi, Farhad

AU - Shami, Paul J.

AU - Stone, Richard M.

AU - Strickland, Stephen A.

AU - Wieduwilt, Matthew

AU - Gregory, Kristina M.

AU - Hammond, Lydia

AU - Ogba, Ndiya

PY - 2019

Y1 - 2019

N2 - Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. Recent advances have resulted in an expansion of treatment options for AML, especially concerning targeted therapies and low-intensity regimens. This portion of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AML focuses on the management of AML and provides recommendations on the workup, diagnostic evaluation and treatment options for younger (age <60 years) and older (age ≥60 years) adult patients.

AB - Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. Recent advances have resulted in an expansion of treatment options for AML, especially concerning targeted therapies and low-intensity regimens. This portion of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AML focuses on the management of AML and provides recommendations on the workup, diagnostic evaluation and treatment options for younger (age <60 years) and older (age ≥60 years) adult patients.

UR - http://www.scopus.com/inward/record.url?scp=85068181660&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2019.0028

DO - 10.6004/jnccn.2019.0028

M3 - Article

C2 - 31200351

AN - SCOPUS:85068181660

SN - 1540-1405

VL - 17

SP - 721

EP - 749

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 6

ER -

Acute myeloid leukemia, version 3.2019

Abstract

Access to Document

Other files and links

Fingerprint

Cite this